| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/24/2000 | WO2000009104A2 Use of sulfonamides for treating vision and memory disorders |
| 02/24/2000 | WO2000009103A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | WO2000009102A2 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | WO2000009098A2 Method for treating ocular neovascular diseases |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999062504A3 Topical administration of oxazolidinones for transdermal delivery |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340745A1 Azepinyland linear compounds and their use for vision and memory disorders |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340668A1 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | CA2340419A1 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2336152A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336147A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | CA2336088A1 Heterocyclic esters or amides for vision and memory disorders |
| 02/24/2000 | CA2336080A1 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336060A1 Small molecule carbamates or ureas for vision and memory disorders |
| 02/24/2000 | CA2335815A1 Compositions and uses for vision and memory disorders |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2335810A1 Use of sulfonamides for treating vision and memory disorders |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028110 Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 02/22/2000 | US6028086 Selective inhibitors of phosphodiesterase (pde) type iv or production of tumor necrosis factor (tnf) and as such are useful treatment of asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | CA2157248C Crystalline form of dihydro-2, 3 benzodiazepine derivative |
| 02/17/2000 | WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008140A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000007974A1 2-fluoro mutilin derivatives |
| 02/17/2000 | WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | WO2000007601A1 Ophtalmic solution with tetracycline for topical treatment of dry eye disease |
| 02/17/2000 | WO2000007591A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/17/2000 | WO2000007565A2 Methods of ophthalmic administration |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |
| 02/17/2000 | WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses |
| 02/17/2000 | WO1999054310A3 New substituted amides, their production and their use |
| 02/17/2000 | WO1999020261A3 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 02/17/2000 | CA2339416A1 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | CA2339340A1 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | CA2339194A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/16/2000 | EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979105A1 Topical nasal antiinflammatory compositions |
| 02/16/2000 | EP0979085A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244864A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 02/15/2000 | US6025494 Tetracyclic derivatives, process of preparation and use |
| 02/15/2000 | US6025392 substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 02/15/2000 | US6025372 Somatostatin agonists |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | CA2180621C New aminophenylphosphonic acid derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 02/15/2000 | CA2119218C Enantioselective synthesis of 5,6-dihydro-(s)-4-(ethylamino)-(s)-6-methyl-4h-thieno 2,3-b thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 02/15/2000 | CA2058398C 1,4 benzothiazine-2-acetic acid derivatives, processes for production thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | WO2000006531A2 Nitric esters and nitrate salts of specific drugs |
| 02/10/2000 | WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | WO2000006169A1 Integrin receptor antagonists |
| 02/10/2000 | WO2000006145A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | WO2000006135A2 Cholinergic agents in the treatment of presbyopia |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 02/10/2000 | WO1999061012A3 Therapeutic dinucleotide and derivatives |
| 02/10/2000 | WO1999060948A3 Medium for treating eye diseases |
| 02/10/2000 | WO1999058139A3 Methods for detecting and inhibiting angiogenesis |
| 02/10/2000 | WO1999049039A3 GFRα3 AND ITS USES |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339093A1 Cholinergic agents in the treatment of presbyopia |
| 02/10/2000 | CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | CA2338275A1 Integrin receptor antagonists |
| 02/10/2000 | CA2336549A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods |
| 02/09/2000 | EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression |
| 02/09/2000 | EP0978515A2 1-(substituted phenyl)-4-biphenylmethyl-imidazol-2-one derivatives, their preparation and their use as angiotensin II antagonists |
| 02/09/2000 | EP0978287A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 02/09/2000 | EP0978284A1 Endothelin antagonist |
| 02/09/2000 | EP0978281A1 Eyedrops |
| 02/09/2000 | EP0977892A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/09/2000 | EP0977880A2 Materials and methods for treatment of retinal diseases |